Adlai Nortye Group Ltd. (ANL) stock
ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.74−0.74 (-7.81%)
Close on Nov 18, 2026Market cap $349.60MP/E –Yield –
Adlai Nortye revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $5.00M, up 0.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.00M | 0.0% |
| FY2023 | Dec 31, 2023 | $5.00M | -89.1% |
| FY2021 | Dec 31, 2021 | $45.73M | – |
See a number that looks wrong?